Bulletin
Investor Alert

New York Markets Close in:

Horizon Therapeutics PLC

NAS: HZNP

GO
/marketstate/country/us

Market open

 --Real time quotes

May 24, 2022, 11:33 a.m.

/zigman2/quotes/206690250/composite

$

88.28

Change

+0.90 +1.02%

Volume

Volume 492,148

Real time quotes

/zigman2/quotes/206690250/composite

Previous close

$ 87.38

$ 88.28

Change

+0.90 +1.02%

Day low

Day high

$87.12

$89.45

Open

52 week low

52 week high

$82.51

$120.54

Open

Irina P. Konstantinovsky

Presently, Irina P. Konstantinovsky is Chief Human Resources Officer & Executive VP of Horizon Therapeutics Plc. She is also on the board of The Human Resources Management Association of Chicago and YWCA of Metropolitan Chicago.

In the past she held the position of Vice President-Global Talent at Baxter International, Inc., Director & Senior Partner at Willis Towers Watson (New York) and Chief Human Resource Officer at Capital BlueCross, Inc.

Irina P. Konstantinovsky received a graduate degree from Cornell University and an undergraduate degree from Universidad de Buenos Aires.

Transactions

Date Shares Transaction Value
02/22/2021 474   Disposition at $88.5 per share. 41,949
02/22/2021 5,224   Disposition at $87.11 per share. 455,063
02/17/2021 696   Derivative/Non-derivative trans. at $87.17 per share. 60,671
02/17/2021 1,571   Award at $0 per share. 0
01/22/2021 2,226   Disposition at $76.81 per share. 170,980
01/21/2021 1,772   Derivative/Non-derivative trans. at $77.43 per share. 137,206
01/21/2021 3,999   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2021 44,184   Derivative/Non-derivative trans. at $73.28 per share. 3,237,804
01/05/2021 60,314   Award at $0 per share. 0
01/05/2021 39,196   Derivative/Non-derivative trans. at $0 per share. 0
09/17/2020 21,351   Derivative/Non-derivative trans. at $14.05 per share. 299,981
09/16/2020 8,919   Disposition at $78.88 per share. 703,531
09/11/2020 7,095   Derivative/Non-derivative trans. at $70.54 per share. 500,482
09/11/2020 16,014   Award at $0 per share. 0
05/06/2020 59,794   Disposition at $41.19 per share. 2,462,915
05/06/2020 59,794   Derivative/Non-derivative trans. at $14.05 per share. 840,105
04/20/2020 19,886   Disposition at $34.13 per share. 678,710
02/19/2020 4,534   Derivative/Non-derivative trans. at $36.06 per share. 163,497
02/19/2020 10,232   Award at $0 per share. 0
01/21/2020 1,772   Derivative/Non-derivative trans. at $38.25 per share. 67,779
01/21/2020 1,825   Derivative/Non-derivative trans. at $38.25 per share. 69,807
01/21/2020 3,998   Award at $0 per share. 0
01/05/2020 21,690   Derivative/Non-derivative trans. at $36.1 per share. 783,009
01/05/2020 19,014   Award at $0 per share. 0
01/05/2020 29,520   Derivative/Non-derivative trans. at $0 per share. 0
09/12/2019 17,838   Disposition at $26.7 per share. 476,275
09/11/2019 7,095   Derivative/Non-derivative trans. at $26.71 per share. 189,508
09/11/2019 16,014   Award at $0 per share. 0
02/20/2019 8,425   Derivative/Non-derivative trans. at $21.54 per share. 181,475
02/20/2019 19,014   Award at $0 per share. 0
01/05/2019 7,962   Derivative/Non-derivative trans. at $20.39 per share. 162,346
01/05/2019 17,259   Derivative/Non-derivative trans. at $0 per share. 0
09/11/2018 7,095   Derivative/Non-derivative trans. at $20.51 per share. 145,519
09/11/2018 16,014   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Timothy P. Walbert
Chairman, President & Chief Executive Officer
Mr. Aaron L. Cox
Chief Financial Officer & Executive Vice President
Dr. Karin Rosen
Chief Scientific Officer
Dr. Elizabeth H. Z. Thompson
Executive Vice President-Research & Development
Dr. Jeffrey W. Sherman
Chief Medical Officer & Executive Vice President
Mr. Michael A. DesJardin
Executive VP-Technical Operations & Quality
Dr. Jeffrey D. Kent
Executive VP-Medical Affairs & Outcomes Research
Mr. Andy Pasternak
Chief Strategy Officer & Executive Vice President
Ms. Holly Copeland
Senior Director-Corporate Social Responsibility
Ms. Marilyn Vetter
Group Vice President-Market Access
Mr. Vikram Karnani
President-International & Executive Vice President
Mr. Miles W. McHugh
Chief Accounting Officer & Senior Vice President
Ms. Tina Ventura
Chief Investor Relations Officer & Senior VP
Ms. Jane Gonnerman
Chief of Staff & Group Vice President-Development
Ms. Irina P. Konstantinovsky
EVP, Chief Human Resources & Diversity Officer
Mr. David Caraher
Secretary
Mr. Sean M. Clayton
Executive Vice President & General Counsel
Dr. Susan Mahony
Independent Director
Mr. Michael G. Grey
Lead Independent Director
Dr. Jeff Himawan
Independent Director
Mr. William Francis Daniel
Independent Director
Ms. Pascale Witz
Independent Director
Dr. James Samuel Shannon
Independent Director
Mr. H. Thomas Watkins
Independent Director
Mr. Gino Santini
Independent Director
Link to MarketWatch's Slice.